January 5, 2018 / 1:20 PM / Updated 4 minutes ago BRIEF-Synlogic Progresses Clinical And Preclinical Pipeline And Outlines 2018 Catalysts Reuters Staff 
Jan 5 (Reuters) - Synlogic Inc: 
* SYNLOGIC PROGRESSES CLINICAL AND PRECLINICAL PIPELINE AND OUTLINES 2018 CATALYSTS 
* SYNLOGIC - EXPECTS TO PRESENT FULL CLINICAL DATA FROM FIRST IN-HUMAN STUDY OF SYNTHETIC BIOTIC MEDICINE EXPECTED IN Q1 2018 
* SYNLOGIC INC - IND FOR SYNB1020 FOR TREATMENT OF HYPERAMMONEMIA IN PATIENTS WITH LIVER DISEASE HAS BEEN CLEARED BY FDA 
* SYNLOGIC INC - ADDITIONAL TRIALS IN PATIENTS WITH UCD AND PKU EXPECTED TO BEGIN IN 2018 Source text for Eikon: Further company coverage: